You are here
Australian Regulatory Guidelines for Advertising Therapeutic Goods (ARGATG)
Print version
Guidance for advertisers
28 October 2020
Version history
This guidance for advertisers applies to the Therapeutic Goods Advertising Code (No.2) 2018. To assist advertisers with implementation, we have also published guidance material: Complying with the Therapeutic Goods Advertising Code (No. 2) 2018.
| Version | Description of change | Author | Effective date |
|---|---|---|---|
| V1.0 | Original publication | Advertising compliance section and Regulatory guidance team | June 2018 |
| V2.0 |
Additional information about:
Some minor editorial changes have also been made |
Advertising compliance section and Regulatory guidance team | July 2018 |
| V2.1 | Minor editorial changes to reflect the making of the Therapeutic Goods Advertising Code (No.2) 2018 (the Code) and the inclusion of the Pricing Information Code of Practice at Schedule 4 of the Code from 1 January 2019. | Advertising Education and Assurance Section | November 2018 |
| V2.2 | Updated Advertising vaccination services and vaccines | Advertising Education and Assurance Section | November 2019 |
| V2.3 | Changes to the information about advertising pre-approvals | Advertising Education and Assurance Section | November 2019 |
| V2.4 | Updated Cosmetic medicine interface | Advertising Education and Assurance Section | December 2019 |
| V2.5 | Changes to reflect the requirement for advertising pre-approval in specified media ending on 30 June 2020 | Advertising Education and Assurance Section | July 2020 |
| V2.6 | Initial changes for complaints handling process improvements | Advertising Education and Assurance Section | August 2020 |
| V2.7 | Changes to restricted representation guidance, including reference to approval checklist | Advertising Education and Assurance Section | October 2020 |
| V2.8 | Updated section on reporting non-compliant advertisements | Advertising Education and Assurance Section | October 2020 |